Kidney Research and Clinical Practice

Search

Page Path

HOME
Search

Review Articles

Novel biomarkers for diabetic kidney disease: Chan-Young Jung, Tae-Hyun Yoo; Kidney Res Clin Pract. 2022;41(Suppl 2):S46-S62. Published online September 30, 2022; DOI: https://doi.org/10.23876/j.krcp.22.084
Cited By 1; Full text PubReader ePub Crossref - TDM PDF

Original Articles

Pathological validation of the Japanese Renal Pathology Society classification and challenges in predicting renal prognosis in patients with diabetic nephropathy: Taeyeong Kim, Yooujin Kwak, Jun Young Lee et al.; Kidney Res Clin Pract. 2022;41(5):545-555. Published online September 30, 2022; DOI: https://doi.org/10.23876/j.krcp.22.123; Full text PubReader ePub Crossref - TDM PDF

Weight change and risk of depression in patients with diabetic kidney disease: a nationwide population-based study: Hong Sang Choi, Bongseong Kim, Kyung-Do Han et al.; Kidney Res Clin Pract. 2023;42(1):86-97. Published online September 8, 2022; DOI: https://doi.org/10.23876/j.krcp.21.294; Full text PubReader ePub Crossref - TDM PDF Supplementary Material

Review Articles

NADPH oxidase inhibitor development for diabetic nephropathy through water tank model: Hye Eun Lee, Seunghwan Shim, Yongseok Choi, Yun Soo Bae; Kidney Res Clin Pract. 2022;41(Suppl 2):S89-S98. Published online July 19, 2022; DOI: https://doi.org/10.23876/j.krcp.21.269
Cited By 1; Full text PubReader ePub Crossref - TDM PDF

Advances in the management of diabetic kidney disease: beyond sodium-glucose co-transporter 2 inhibitors: Anthony T. P. Chan, Sydney C. W. Tang; Kidney Res Clin Pract. 2022;41(6):682-698. Published online July 19, 2022; DOI: https://doi.org/10.23876/j.krcp.21.285
Cited By 1; Full text PubReader ePub Crossref - TDM PDF

GLP-1 receptor agonists in diabetic kidney disease: current evidence and future directions: Ji Hee Yu, So Young Park, Da Young Lee, Nan Hee Kim, Ji A Seo; Kidney Res Clin Pract. 2022;41(2):136-149. Published online March 25, 2022; DOI: https://doi.org/10.23876/j.krcp.22.001
Cited By 2; Full text PubReader ePub Crossref - TDM PDF

Exploring molecular targets in diabetic kidney disease: Sayako Maruno, Tetsuhiro Tanaka, Masaomi Nangaku; Kidney Res Clin Pract. 2022;41(Suppl 2):S33-S45. Published online March 15, 2022; DOI: https://doi.org/10.23876/j.krcp.21.251
Cited By 9; Full text PubReader ePub Crossref - TDM PDF

Original Articles

Urinary exosomal microRNA profiling in type 2 diabetes patients taking dipeptidyl peptidase-4 inhibitor compared with sulfonylurea: Nam-Jun Cho, Dae-Yeon Kim, Soon Hyo Kwon et al.; Kidney Res Clin Pract. 2021;40(3):383-391. Published online July 7, 2021; DOI: https://doi.org/10.23876/j.krcp.21.015
Cited By 5; Full text PubReader ePub Crossref - TDM PDF Supplementary Material

Manifestation of rs1888747 polymorphisms in the FRMD3 gene in diabetic kidney disease and diabetic retinopathy in type 2 diabetes patients: Chatchai Kreepala, Pitirat Panpruang, Rapeeporn Yodprom et al.; Kidney Res Clin Pract. 2021;40(2):263-271. Published online June 2, 2021; DOI: https://doi.org/10.23876/j.krcp.20.190; Full text PubReader ePub Crossref - TDM PDF

Nrf2-Heme oxygenase-1 modulates autophagy and inhibits apoptosis triggered by elevated glucose levels in renal tubule cells: Joo-Heon Kim, Kyeong Min Kim, Jin Uk Jeong, Jong Ho Shin, Jae Min Shin, Ki Tae Bang; Kidney Res Clin Pract. 2019;38(3):318-325. Published online September 30, 2019; DOI: https://doi.org/10.23876/j.krcp.18.0152
Cited By 13; Full text PubReader Crossref - TDM PDF

Review Articles

Noncoding RNAs as therapeutic targets in early stage diabetic kidney disease: Mitsuo Kato; Kidney Res Clin Pract. 2018;37(3):197-209. Published online September 30, 2018; DOI: https://doi.org/10.23876/j.krcp.2018.37.3.197
Cited By 28; Full text PubReader Crossref - TDM PDF

Pathology identifies glomerular treatment targets in diabetic nephropathy: Charles E. Alpers, Kelly L. Hudkins; Kidney Res Clin Pract. 2018;37(2):106-111. Published online June 30, 2018; DOI: https://doi.org/10.23876/j.krcp.2018.37.2.106
Cited By 16; Full text PubReader Crossref - TDM PDF

The Efficacy of Urinary Albumin-to-Osmolality Ratio in Predicting 24-hour Urine Albumin Excretion in Type 2 DM Patients: Ju Hyun Lee, M.D., So Young Kim, M.D., Min Ji Lee, M.D., Soon Ae Kim, M,D., Sung Joon Shin, M.D. and Kyung Soo Kim, M.D.; Korean J Nephrol. 2011;30(6):601-606.; PDF

Over-expression of Liver X Receptor- α (LXRα) by TO901317 Exaggerated the Production of Mesangial Matrix: Ho Jun Chin, M.D., Ph.D, Yan Yan Fu, M.D. Young Rim Song, M.D. En Sung Lee Yun Mi Lee Seong Gyun Kim, M.D., Ph.D. Ki Young Na, M.D., Ph.D. Suhnggwon Kim, M.D., Ph.D. and Dong-Wan Chae, M.D., Ph.D.; Korean J Nephrol. 2010;29(2):189-197.; PDF

Combination Treatment with Retinoid and Peroxisome Proliferator-Activated Receptors (PPAR)-γ Agonist on Streptozotocin-Induced Diabetic Nephropathy: Sang-Youb Han, M.D. Cy-Hyun Kim, M.D. Kum-Hyun Han, M.D. Dae-Ryong Cha, M.D. and Han-Seong Kim, M.D.; Korean J Nephrol. 2007;26(5):526-533.; PDF

Volume 42, No. 3

Kidney Research
and
Clinical Practice

Print ISSN: 2211-9132
Online ISSN: 2211-9140

MOST VIEWED MOST CITED

8,678	Recent advances in electron microscopy for the diagnosis and research of glomerular diseases
30,959	Uremic pruritus: pathophysiology, clinical presentation, and treatments
5,539	Updates in renal pathology
8,448	Management of autosomal dominant polycystic kidney disease in the era of disease-modifying treatment options
1,762	Zebra bodies in lupus nephritis after hydroxychloroquine therapy

Cited By 38	Trends in epidemiologic characteristics of end-stage renal disease from 2019 Korean Renal Data System (KORDS)
Cited By 20	Implications of oxidative stress in chronic kidney disease: a review on current concepts and therapies
Cited By 13	Intestinal microbiota and kidney diseases
Cited By 11	Association between copeptin levels and treatment responses to hypertonic saline infusion in patients with symptomatic hyponatremia: a prospective cohort study
Cited By 10	Fabry disease exacerbates renal interstitial fibrosis after unilateral ureteral obstruction via impaired autophagy and enhanced apoptosis

Editorial Office: #301, (Miseung Bldg.) 23, Apgujenog-ro 30-gil, Gangnam-gu, Seoul 06022, Korea
Tel: +82-2-3486-8736 Fax: +82-2-3486-8737 E-mail: registry@ksn.or.kr

Copyright © 2023 by The Korean Society of Nephrology.